Fmr LLC Has $113.47 Million Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Fmr LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 34.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,890,754 shares of the company’s stock after selling 2,625,694 shares during the period. Fmr LLC’s holdings in Option Care Health were worth $113,466,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Cornerstone Investment Partners LLC raised its position in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. lifted its position in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares in the last quarter. Assetmark Inc. grew its holdings in Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after acquiring an additional 487 shares during the last quarter. Pacer Advisors Inc. raised its stake in shares of Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after acquiring an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management lifted its position in shares of Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after purchasing an additional 550 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $31.84 on Tuesday. The company has a market capitalization of $5.23 billion, a price-to-earnings ratio of 26.76, a P/E/G ratio of 2.30 and a beta of 1.07. The firm’s 50 day simple moving average is $33.25 and its 200 day simple moving average is $28.59. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Wall Street Analyst Weigh In

OPCH has been the subject of several research analyst reports. JMP Securities restated a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.